Follicular fluid glycosaminoglycans inhibit degradation of low-density lipoproteins and progesterone production by porcine granulosa cells.
Porcine granulosa cells were incubated with commercially available glycosaminoglycans (GAGs) or GAGs purified from porcine follicular fluid to evaluate the effects of GAGs on degradation of low-density lipoproteins (LDL) and progesterone production. Commercially available heparin and chondroitin sulfates (CS) as well as follicular CS and heparan sulfate (HS) inhibited degradation of LDL in dose-dependent manners. Doses of follicular CS and HS required to inhibit 50% of the LDL degradation corresponded to concentrations found in follicular fluid (less than 1 mg/ml). Progesterone production was also inhibited in a dose-dependent fashion by follicular GAGs at concentrations found in follicles. The ability of the follicular GAGs to inhibit degradation of LDL could represent a mechanism by which the utilization of LDL-derived sterol is temporarily restricted following permeabilization of the ovulatory follicle. Follicular GAGs may also modulate utilization of apoprotein E-containing high-density lipoproteins in unruptured follicles.
D000818:Animals; D001826:Body Fluids / Q000502:physiology; D002478:Cells, Cultured; D002809:Chondroitin Sulfates / Q000502:physiology; D002852:Chromatography, Ion Exchange; D005260:Female; D006025:Glycosaminoglycans / Q000502:physiology*; D006107:Granulosa Cells / Q000378:metabolism*; D006497:Heparan Sulfate / Q000502:physiology; D008077:Lipoproteins, LDL / Q000378:metabolism*; D006080:Ovarian Follicle / Q000502:physiology*; D011374:Progesterone / Q000096:biosynthesis*; D013552:Swine
D002809:Chondroitin Sulfates; D006025:Glycosaminoglycans; D006497:Heparan Sulfate; D008077:Lipoproteins, LDL; D011374:Progesterone